Soof Solutions Inc.’s Post

🚀 #PortugalEconomicForum on #Health & #Innovation | November 21, 2024 | Harvard Club, NYC 🌍 This year’s forum will explore one of the most transformative sectors today: #Health & #Innovation, spotlighting #Portugal’s remarkable achievements and the nation’s future ambitions in shaping the #global healthcare landscape. Join us for a thought-provoking event featuring three dynamic panels: 🔍 #ECOSYSTEM, #TRENDS AND #OPPORTUNITIES IN #USA HEALTH AND INNOVATION SECTOR Discover the current landscape of health innovation in the U.S., exploring emerging trends, opportunities, and the future of healthcare. 💡 PORTUGAL IN THE #WORLD #PHARMA INDUSTRY Explore how Portugal is positioning itself on the world stage in the pharmaceutical sector, with key contributions and ambitious future goals. 🧬 #BIOTECH #INNOVATION IN PORTUGAL AND PARTNERSHIP WITH #AMERICAN COMPANIES Learn about cutting-edge biotech innovations in Portugal and the importance of fostering partnerships with U.S. companies to drive forward global health solutions. This forum promises to be an unparalleled opportunity to connect with industry leaders, innovators, and policymakers from both sides of the Atlantic. 🌍🤝 #PortugalEconomicForum #HealthInnovation #Pharma #Biotech #Healthcare #Innovation #GlobalHealth #USPortugal #FutureOfHealthcare #NYCEvents #HarvardClub

#event On the 26th of November, Cláudia Lobato da Silva and Sofia Aires Martins from #iBB had the privilege to participate in the DG RTD Workshop: Supporting the Translation of Research Results and the Development of Health Biotech Innovations for Greater European Benefit. The event focused on advancing #biotech innovation and #manufacturing across the EU, emphasizing the need to bridge the gap between groundbreaking research and impactful health solutions. Key takeaways from the workshop discussions: ✔️ The EU is home to #excellent #research centers, driving innovation across its territory. ✔️ #Collaboration without borders is undeniably an EU competitive advantage. To unlock its full potential, the EU should address key challenges: - Enhanced #funding for translational research. - Smarter and #adaptive regulations to support innovation. - Ensuring consistent access to cutting-edge #infrastructures and #resources. 💡 Let’s work together to shape the future of #biotech_innovation and deliver meaningful health solutions for the benefit of all Europeans.

#Várhelyi’s recent responses to the #European #Parliament raised some interesting points, but these three quotes really stood out to me as crucial for the future of Pharma and Medtech in Europe - though there are still many questions to be asked: 💊 Regulatory reform: “We need a regulatory framework suited to the rapid pace of technological change…that makes it more attractive for companies to invest in research and development for innovative medicines in the EU, including specific incentives for medicines for rare diseases.” 🔬 Supply chain resilience: “Through a Critical Medicines Act, I will tackle the endemic risks of shortages of critical medicines and medical devices, and reduce dependencies…to ensure Europe is prepared for future health threats.” 🧠 Biotech and AI: “Biotechnology, artificial intelligence, and data from the European Health Data Space are of strategic importance for the EU’s long-term competitiveness. They can help in the development of novel therapies and innovative products, including for rare diseases.” While these are all steps in the right direction, the devil is in the details. It’ll be interesting to see how these ideas translate into real progress for our industry. #HealthcareInnovation #Pharma #MedTech #PublicAffairs #Biotech #EURegulation

Innovation, challenges, and untapped potential characterise Africa's emerging #MedTech industry. As the continent navigates its unique healthcare landscape, the promise of medical technology stands as one of the avenues for effectively addressing pressing healthcare needs. From diagnostics to assistive technology, the MedTech sector in Africa has the potential for significant growth and impact. So why is the creation and manufacturing of MedTech increasingly vital for the African continent? Read our full blog and learn more about TAMC 2024 here: https://lnkd.in/dhwRNdth Wambui Nyabero Sewu-Steve T. Jaza Rift Robert Karanja, PhD Wilfred Njagi Rob Beyer Winnie Kibiru Stacy Awinja , MIEEE The Lemelson Foundation Rice360 Institute for Global Health Technologies Kenyatta University Villgro Africa

We paid a courtesy call as Kabani Pharmaceuticals Ltd to the Minister of Technology and Science, among many things discussed was how Zambian pharmaceuticals can leverage on technology and AI in improving access to health care especially in rural places. Access to real time consumption data of essential medicines in rural health facilities is a challenge. As stakeholders we are duty bound to ensure universal health coverage a thing that can only materialize with timely and availability of accurate consumption data. Pic: Hon Felix Mutati and Mr Kabani Steve.

R&I community, anyone in Brussels tomorrow? I will be attending a meeting organized by the European Commission - Directorate-General for Research and Innovation - aiming to support the translation of research results and the development of health biotech innovations for greater European benefit. (9:30-10:45) Opening session: - Welcome & research implications of the Biotech Communication (Irene Norstedt, Director, DG RTD) - EU collaborative R&I projects in the field of health biotechnology (Angelo Marino, Health and Food Department, HaDEA) - Bottom-up EU initiatives supporting Research & Innovation (e.g. EIC, ERCEA, STEP) (11:15-12:30) Panel discussion: What are the EU strengths in health biotechnologies and how can Collaborative Research across Europe reinforce this leadership? Moderator: Carmen Laplaza Santos, Health Innovations and Ecosystems This session aims at identifying in which areas of health biotechnology Europe performs well, what are the drivers of their success and how to ensure that the EU remains an attractive environment to perform Health biotech research. The panel represents the various stakeholders within the health research ecosystem (infrastructures, academic researchers, clinicians, SME’s and partnerships with industry) who will share their own experiences and discuss with audience. (13:30-15:00) Roundtable discussions (breakout groups) • What are the opportunities or gaps where research can make the difference? • How can R&I help in overcoming the technical challenges for the field to translate more research results into health biotech products and services? • What infrastructures are needed to further boost EU competitiveness in the field? • Where would collaboration of academia or SMEs with industry be beneficial to progress health biotech? • What strategies could be suitably adoptable to tackle public acceptance of biotechnology innovations? Short break (15:15-16:30) Conclusions Moderator: Irene Norstedt o Report back from each breakout group o Collective discussion on the main points o Art, Science and Biotechnology: the experience of S+T+ARTS Initiative • Wrap-up & next steps #knowledgetransfer #techtransfer #valuecreation #healthbiotech

More equitable and fair distribution of biomedical innovation is a shared responsibility. Our report maps out relevant initiatives on public return and provides recommendations to a range of stakeholders. Read the report here: https://lnkd.in/eECdY-uv

𝗞𝗮𝗿𝗼𝗹𝗶𝗻𝘀𝗸𝗮 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲𝘁’𝘀 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗺𝗼𝗱𝗲𝗹 𝗼𝗽𝗲𝗻𝘀 𝘁𝗵𝗲 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻 𝗗𝗮𝘆 CERCA organizes the Connection Day opening conference with Johan Weigelt, CEO of Karolinska Institutet Innovations AB. Johan Weigelt conference organized by CERCA opened the second edition of the Connection Day, an initiative by CataloniaBio & HealthTech to connecting and gathering within the health sector. Weigelt talked about the close relationship among academia, healthcare, and industry and underlined the specificities of the Swedish system as the so-called ‘Professors privilege’, which means that intellectual properties are owned by professors and investigators. “This system has pros and cons, but it works” he said. 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗸𝗲𝘆𝘀 𝘁𝗼 𝘀𝘂𝗰𝗰𝗲𝘀𝘀 The KI Innovations AB holding company sells services to promote the commercialization of research and develop start-ups in a three-phase program (idea promotion, consolidation, and maturation, in a final incubator phase that lasts three years). For Weigelt, its strength lies in “having a very strong research base and a good network of industrial experts and business 'coaches'”. #SomCERCA #Research #Innovation

🌍 Boosting European Competitiveness in Life Sciences: Key Insights from the New Political Guidelines As we look towards the future, the European Commission's Political Guidelines for 2024-2029 highlight crucial areas to enhance our competitiveness in the life sciences sector. Here are some key takeaways: Focus on Digitalisation and R&D: Emphasizing the importance of research and development, the guidelines advocate for a dedicated life sciences strategy to foster innovation and collaboration. Investment in Innovation: To lead in innovation, Europe must create an environment where researchers can thrive. This includes establishing public-private partnerships that provide the necessary infrastructure and resources. Data Revolution Needed: President Ursula von der Leyen calls for a data revolution to improve productivity. Many European companies face challenges accessing essential data, which hampers their competitiveness against larger foreign tech firms. Proposed European Biotech Act: Set to launch in 2025, this act aims to facilitate the transition of biotech innovations from laboratories to the market, supporting both green and digital transitions. Addressing Medicine Shortages: The guidelines propose a Critical Medicines Act to tackle the shortages of vital medicines, ensuring a stable supply and reducing dependency on a limited number of suppliers. As professionals in the life sciences and related fields, it's essential to stay informed and engaged with these developments. Together, we can contribute to a more competitive and innovative Europe! 💡 #LifeSciences #Innovation #DigitalTransformation #EuropeanCommission #Biotech #Healthcare #Competitiveness #ResearchAndDevelopment #DataRevolution #MedicineShortages

Tune in to the video and explore the perspectives shared by Christian Rodseth, Vice President PIF, at Delphi Economic Forum, focusing on how innovation attracts investment, empowers economic growth while strengthening the national Health Care system sustainability. #delphiforum #pifgreece #innovation #pharma